Trodelvy granted accelerated approval by USFDA for metastatic urothelial cancer

The USFDA’s accelerated approval procedure allows drugs treating serious diseases with unmet medical needs to be approved on the basis of a surrogate or intermediate clinical endpoint. Credit: Sammy-Williams/Pixabay.